These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2018239)

  • 21. Normalization of coronary vasomotion after percutaneous transluminal coronary angioplasty?
    Suter TM; Buechi M; Hess OM; Haemmerli-Saner C; Gaglione A; Krayenbuehl HP
    Circulation; 1992 Jan; 85(1):86-92. PubMed ID: 1728488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group.
    Weintraub WS; Boccuzzi SJ; Brown CL; Cohen CL; Hirsch LJ; King SB; Alexander RW
    Am J Cardiol; 1992 Aug; 70(3):293-9. PubMed ID: 1632391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA.
    Franzen D; Schannwell M; Oette K; Höpp HW
    Cathet Cardiovasc Diagn; 1993 Apr; 28(4):301-10. PubMed ID: 8462079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of dipyridamole-atropine stress echocardiography for detection of patients with restenosis after PTCA].
    Scherhag A; Pfleger S; Schreckenberger A; Simonis B; Staedt U; Heene DL
    Z Kardiol; 1996 Aug; 85(8):570-9. PubMed ID: 8975497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease.
    Musci M; Loebe M; Wellnhofer E; Meyer R; Pasic M; Hummel M; Bocksch W; Grauhan O; Weng Y; Hetzer R
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):268-74. PubMed ID: 9885117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
    Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
    Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cilostazol, a novel anti-platelet drug, on restenosis after percutaneous transluminal coronary angioplasty.
    Tsutsui M; Shimokawa H; Higuchi S; Yoshihara S; Hayashida K; Sobashima A; Kuga T; Matsuguchi T; Okamatsu S
    Jpn Circ J; 1996 Apr; 60(4):207-15. PubMed ID: 8726169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and long-term results of angioplasty for multiple coronary stenoses.
    Halon DA; Flugelman MY; Shefer A; Shehadeh H; Merdler A; Turgeman Y; Lewis BS
    Isr J Med Sci; 1988 Mar; 24(3):164-71. PubMed ID: 2967264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
    Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
    Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between morphology of restenosis and clinical aspects in patients who had undergone coronary angioplasty].
    Bramucci E; de Servi S; Ghio S; Cioffi P; Angoli L; Barberis P; Ferrario M; Poma E; Ardissino D; Montemartini C
    G Ital Cardiol; 1988 Oct; 18(10):819-23. PubMed ID: 2977595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of residual collaterals immediately after successful coronary angioplasty.
    Watarai M; Takatsu F; Shimizu S; Nishiyama A; Shiga Y; Furuta T
    Jpn Heart J; 1992 Sep; 33(5):643-51. PubMed ID: 1289596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte activation in restenosis after percutaneous transluminal coronary angioplasty.
    Tsutsui M; Shimokawa H; Tanaka S; Yoshihara S; Higuchi S; Matsuguchi T; Okamatsu S
    Jpn Circ J; 1996 Jan; 60(1):27-34. PubMed ID: 8648881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of restenosis after percutaneous transluminal coronary angioplasty using the exercise treadmill test and technetium 99m-sestamibi scintigraphy.
    Srimahachota S; Limpijankit T; Boonyaratavej S; Tepmongkol S; Udayachalerm W; Suithichaiyakul T; Ngarmukos P
    J Med Assoc Thai; 2001 Mar; 84(3):307-13. PubMed ID: 11460930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of risk factors for restenosis after PTCA.
    Rupprecht HJ; Brennecke R; Bernhard G; Erbel R; Pop T; Meyer J
    Cathet Cardiovasc Diagn; 1990 Mar; 19(3):151-9. PubMed ID: 2317853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study.
    Cairns JA; Gill J; Morton B; Roberts R; Gent M; Hirsh J; Holder D; Finnie K; Marquis JF; Naqvi S; Cohen E
    Circulation; 1996 Oct; 94(7):1553-60. PubMed ID: 8840843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of low-dose aspirin on restenosis after coronary angioplasty.
    Taylor RR; Gibbons FA; Cope GD; Cumpston GN; Mews GC; Luke P
    Am J Cardiol; 1991 Oct; 68(9):874-8. PubMed ID: 1927946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lesion-related factors associated with restenosis after percutaneous transluminal coronary angioplasty in the absence of patient-related factors].
    Sakai Y; Tomobuchi Y; Hashizume T; Imanishi T; Tomimoto S; Toyoda Y; Arita M; Hano T; Nishio I
    J Cardiol; 1997 Jan; 29(1):1-6. PubMed ID: 9023673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restenosis after multilesion percutaneous transluminal coronary angioplasty.
    Vandormael MG; Deligonul U; Kern MJ; Kennedy H; Galan K; Chaitman B
    Am J Cardiol; 1987 Jul; 60(3):44B-47B. PubMed ID: 2956841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of pravastatin on prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
    Onaka H; Hirota Y; Kita Y; Tsuji R; Ishii K; Ishimura T; Kawamura K
    Jpn Circ J; 1994 Feb; 58(2):100-6. PubMed ID: 8196151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.